The nature of an identified dystrophin mutation often affords some clinical insight into prognosis—Duchenne results from complete absence of the dystrophin gene, where the milder “Becker” muscular dystrophy (BMD) results from various partial impairments of dystrophin abundance or function. Here, DMD is linked to muscular dystrophy.